Recently, epigenetic targeted therapies have been shown to trigger an IFN antiviral response in several cancer types, including PCa, mounting an innate immune response and resulting in the production of many cytokines [74–77]. The gene discussed is IFNA1; the disease is posterior cortical atrophy.